GO
Loading...

Biotech & Drug Stocks: Scotus Ruling Impact

Wednesday, 27 Jun 2012 | 5:15 PM ET

The biotech sector is up more than 1 percent today, and discussing what investors can expect after tomorrow's health care reform ruling, with ISI's biotech and pharmaceuticals major analyst Mark Schoenebaum. "If tomorrow the whole bill is struck down, technically, earnings and revenue estimates for all of biotech and all of pharma companies are going to go up," says Schoenebaum.